Severe RSV can lead to serious outcomes. Elderly or immunocompromised patients in Singapore face an increased risk of ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Medical risk-based approaches outperformed age-based strategies, even when vaccine prices were low, the study authors said.

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

As RSV approaches, some "real world" data out of France provides even more support for the RSV antibody shot for babies.

Yes, the RSV vaccine is available for our patients. Ask a member of your care team for more information. You don’t have to get vaccinated at MSK. Go to vaccines.gov to get a vaccine near you.

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

After the COVID-19 pandemic subsided, children who were hospitalized for respiratory syncytial virus infections were older ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

New York hospitals are treating an increased number of alternative-level of care patients, another example of bed shortages ...